Recent insider selling at BioMarin Pharmaceutical raises cau...
Recent insider selling at BioMarin Pharmaceutical raises caution despite high insider ownership. The history of share sales is concerning, though the company's earnings growth is positive.
Insiders At BioMarin Pharmaceutical Sold US$6.7m In Stock, Alluding To Potential Weakness
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3169Followers
0Following
7921Visitors
Follow